Designing with care team needs in mind [innovation design and adaptability]
SAID
Many clinical stakeholders said that they lacked the time and resources to address symptoms during clinic visits. They liked that the intervention would augment the support they provided without impacting their workload directly, but they worried that the intervention could increase the amount and scope of patients’ questions:I think offering prophylactic and proactive assessment and questioning is a good thing. We just need to have a good sense of what the impact is going to be. Because if you put yourself out there, and you make yourself available more consistently… You might be getting things that maybe require attention that are unrelated to oncology care. (P16; Nurse Practitioner)Past experiences with external interventionists raised concerns about symptoms being addressed by SCMs external to their oncology team. Stakeholders emphasized the importance of being alerted to more serious symptoms, but not to less serious ones, requiring SCMs to make that determination.Their biggest concern is that we’re integrating enough, but not too much, with the care teams such that they know what’s going on with the intervention, but not that they’re inundated with extra questions, in-baskets, calls from patients. (P5; Nurse Supervisor)